Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jersy Cardenas"'
Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2016)
In patients with active acromegaly after pituitary surgery, somatostatin analogues are effective in controlling the disease and can even be curative in some cases. After treatment discontinuation, the likelihood of disease recurrence is high. However
Externí odkaz:
https://doaj.org/article/41ffd09cb52d4c93af5306e6f76ec113
Autor:
Clotilde Vazquez, Bogdana L Luca, Jersy Cardenas, Alvaro Sanchez, Teresa Montoya, Paula Labeira, Belen Gutierrez, Yvonne Fernandez, Roberto Sierra, Diego Meneses
Publikováno v:
Advances in Obesity, Weight Management & Control. 11:155-157
Obesity is one of the most important health issues worldwide. According to the Mexican National Survey of Health and Nutrition 2018 “ENSANUT”, 76.8% of women and 73% of men who are 18 years or older are overweight or obese, and the majority are n
Autor:
Vega Cristina Cruces, Sanz–Pastor Alba Galdon, Martinez Clotilde Vazquez, Jersy Cardenas, Mostoles Naiara Modroño, Rodriguez Maria Jesus Silva, La Paz Gómez Montes María De, Los Angeles Gonzalo Redondo Maria De, Gomez Nancy Sanchez, Luca Bogdana Luiza, González Diego Meneses, Alvarez Teresa Montoya, Sanchez Jorge Ruiz, Sierra Poyatos Roberto Miguel, Juaristi Maite Ortega
Publikováno v:
Endocrine Abstracts.
Autor:
Silva Rodriguez Maria Jesus, Alvarez Enrique Perez, Gomez Nancy Sanchez, Martinez Clotilde Vazquez, Pilar Barrio, Montesinos Irene Gonzalo, Lopez Raquel Sanchez, Mostoles Naiara Modroño, Alvarez Teresa Montoya, De la Cruz Fernandez Maria Jose, Jersy Cardenas, Luca Bogdana Luiza, Lechuga Begoña Sanchez, Alicia Estrella, Vega Eva Cruces, Sierra Poyatos Roberto Miguel
Publikováno v:
Endocrine Abstracts.
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 5, p 1682 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 5, p 1682 (2020)
Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of somatotropinomas, thyrotropinomas, and functioning and non-functioning gastroenteropancreatic neuroendocrine tumors. They should also be considered an effecti
Publikováno v:
Endocrines, Vol 3, Iss 4, Pp 726-735 (2022)
We evaluated the hospital evolution of hyponatremia and inflammation markers in patients with coronavirus disease 2019 (COVID-19). The hospital evolutions of a cohort of adult patients with COVID-19 pneumonia and hyponatremia were retrospectively ana
Externí odkaz:
https://doaj.org/article/cfe1251ad70c44a288ea42e40ea4c901
Autor:
Cristina Álvarez-Escolá, Beatriz Pelegrina, Angel Sanz‐Valtierra, Jersy Cardenas-Salas, Beatriz Lecumberri
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Clinical Case Reports
Consejería de Sanidad de la Comunidad de Madrid
Clinical Case Reports
Key Clinical Message Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be rul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::432ae08473dc90238f1b38ebfa20f770
https://hdl.handle.net/20.500.12530/20071
https://hdl.handle.net/20.500.12530/20071
Autor:
Jorge Gabriel Ruiz-Sánchez, Martín Cuesta, Emilia Gómez-Hoyos, Jersy Cárdenas-Salas, Miguel Ángel Rubio-Herrera, Estefanía Martínez-González, Paz De Miguel Novoa, Jara Eloisa Ternero-Vega, Alfonso Luis Calle-Pascual, Isabelle Runkle
Publikováno v:
Medicina, Vol 58, Iss 7, p 851 (2022)
Background and Objectives: Differentiating between hypovolemic (HH) and euvolemic hyponatremia (EH) is crucial for correct diagnosis and therapy, but can be a challenge. We aim to ascertain whether changes in serum creatinine (SC) can be helpful in d
Externí odkaz:
https://doaj.org/article/3761671d40034150b8aabbee66a818f8
Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
Publikováno v:
Europe PubMed Central
Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2016)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2016)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
In patients with active acromegaly after pituitary surgery, somatostatin analogues are effective in controlling the disease and can even be curative in some cases. After treatment discontinuation, the likelihood of disease recurrence is high. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6f5f12a1af3b0476850db278e663af
http://europepmc.org/abstract/med/27933171
http://europepmc.org/abstract/med/27933171